APG Asset Management N.V. decreased its position in Ralliant Corporation (NYSE:RAL – Free Report) by 75.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,803 shares of the company’s stock after selling 61,433 shares during the period. APG Asset Management N.V.’s holdings in Ralliant were worth $866,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in RAL. Clean Energy Transition LLP lifted its position in Ralliant by 70.1% in the third quarter. Clean Energy Transition LLP now owns 900,903 shares of the company’s stock valued at $39,396,000 after purchasing an additional 371,419 shares during the period. American Century Companies Inc. increased its position in Ralliant by 619.2% during the 3rd quarter. American Century Companies Inc. now owns 1,193,997 shares of the company’s stock worth $52,214,000 after purchasing an additional 1,027,991 shares during the period. Huntington National Bank purchased a new position in shares of Ralliant during the 3rd quarter worth approximately $103,000. Quantbot Technologies LP acquired a new stake in shares of Ralliant in the 3rd quarter valued at approximately $3,033,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Ralliant in the third quarter valued at approximately $143,000.
Ralliant Stock Down 2.0%
RAL stock opened at $45.81 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The company’s 50 day simple moving average is $49.28 and its 200-day simple moving average is $46.63. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The firm has a market capitalization of $5.12 billion and a PE ratio of 23.37.
Ralliant Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.
Analysts Set New Price Targets
Several research analysts have issued reports on RAL shares. Morgan Stanley reiterated an “overweight” rating and issued a $45.00 price objective on shares of Ralliant in a research report on Friday, February 6th. Weiss Ratings cut shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Truist Financial cut their price target on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Oppenheimer dropped their target price on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $50.50.
Insider Buying and Selling
In other news, SVP Amir A. Kazmi bought 2,545 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was purchased at an average price of $39.27 per share, with a total value of $99,942.15. Following the purchase, the senior vice president owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Kate Mitchell purchased 2,350 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were purchased at an average cost of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the purchase, the director directly owned 8,411 shares in the company, valued at $357,299.28. The trade was a 38.77% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 8,145 shares of company stock worth $332,233.
Ralliant Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
See Also
- Five stocks we like better than Ralliant
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
